8-K

Company

Arcus Biosciences, Inc.

Filed

November 7, 2023

Period of Report

November 7, 2023

Accession Number

0001724521-23-000018

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →